Neurocardiogenic syncope epidemiology and demographics

WikiDoc Resources for Neurocardiogenic syncope epidemiology and demographics
Articles
Most recent articles on Neurocardiogenic syncope epidemiology and demographics Most cited articles on Neurocardiogenic syncope epidemiology and demographics Review articles on Neurocardiogenic syncope epidemiology and demographics Articles on Neurocardiogenic syncope epidemiology and demographics in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Neurocardiogenic syncope epidemiology and demographics Images of Neurocardiogenic syncope epidemiology and demographics Photos of Neurocardiogenic syncope epidemiology and demographics Podcasts & MP3s on Neurocardiogenic syncope epidemiology and demographics Videos on Neurocardiogenic syncope epidemiology and demographics
Evidence Based Medicine
Cochrane Collaboration on Neurocardiogenic syncope epidemiology and demographics Bandolier on Neurocardiogenic syncope epidemiology and demographics TRIP on Neurocardiogenic syncope epidemiology and demographics
Clinical Trials
Ongoing Trials on Neurocardiogenic syncope epidemiology and demographics at Clinical Trials.gov Trial results on Neurocardiogenic syncope epidemiology and demographics Clinical Trials on Neurocardiogenic syncope epidemiology and demographics at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Neurocardiogenic syncope epidemiology and demographics NICE Guidance on Neurocardiogenic syncope epidemiology and demographics NHS PRODIGY Guidance FDA on Neurocardiogenic syncope epidemiology and demographics CDC on Neurocardiogenic syncope epidemiology and demographics
Books
Books on Neurocardiogenic syncope epidemiology and demographics
News
Neurocardiogenic syncope epidemiology and demographics in the news Be alerted to news on Neurocardiogenic syncope epidemiology and demographics News trends on Neurocardiogenic syncope epidemiology and demographics
Commentary
Blogs on Neurocardiogenic syncope epidemiology and demographics
Definitions
Definitions of Neurocardiogenic syncope epidemiology and demographics
Patient Resources / Community
Patient resources on Neurocardiogenic syncope epidemiology and demographics Discussion groups on Neurocardiogenic syncope epidemiology and demographics Patient Handouts on Neurocardiogenic syncope epidemiology and demographics Directions to Hospitals Treating Neurocardiogenic syncope epidemiology and demographics Risk calculators and risk factors for Neurocardiogenic syncope epidemiology and demographics
Healthcare Provider Resources
Symptoms of Neurocardiogenic syncope epidemiology and demographics Causes & Risk Factors for Neurocardiogenic syncope epidemiology and demographics Diagnostic studies for Neurocardiogenic syncope epidemiology and demographics Treatment of Neurocardiogenic syncope epidemiology and demographics
Continuing Medical Education (CME)
CME Programs on Neurocardiogenic syncope epidemiology and demographics
International
Neurocardiogenic syncope epidemiology and demographics en Espanol Neurocardiogenic syncope epidemiology and demographics en Francais
Business
Neurocardiogenic syncope epidemiology and demographics in the Marketplace Patents on Neurocardiogenic syncope epidemiology and demographics
Experimental / Informatics
List of terms related to Neurocardiogenic syncope epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Neurocardiogenic syncope is the most common cause of syncope in children and adults.

Incidence

The prevalence is 22% in the general population. Approximately 50%-66% of syncope cases are classified as due to vasovagal syncope.